Use of the mucoregulator ascoril for respiratory diseases
Shmeleva, N.M.
Terapevticheskii Arkhiv 84(10): 86-90
2012
ISSN/ISBN: 0040-3660 PMID: 23227508 Document Number: 656181
The paper deals with the use of the combined mucoregulatory drug ascoril in pulmonological care. Due to its multicomponent composition, the drug has mucoregulatory properties that combine a bronchodilator effect and an ability to dilute sputum and to synthesize the surfactant. The mechanism of action of each ascoril component is analyzed; the results of basic experimental and clinical studies on the use of the drug are given. A wide range of indications, such as respiratory system diseases, for ascoril use is demonstrated.
Document emailed within 1 workday
Related Documents
Szczuka, I.; Leowski, J.; Miller, M.; Werens, S. 1978: Epidemiologic studies on respiratory diseases in Płock. IV. Selected environmental factors and symptoms of chronic non-specific respiratory diseases Pneumonologia Polska 46(9): 647-653Wiatr, E. 1981: Phagocytosis and nitroblue tetrazolium reduction tests in respiratory tract diseases. II. Disorders of granulocyte function in respiratory tract diseases Pneumonologia Polska 49(6): 417-425
Ainapure, S.S.; Desai, A.; Korde, K. 2001: Efficacy and safety of Ascoril in the management of cough--National Study Group report Journal of the Indian Medical Association 99(2): 111 114
Takami, H. 2006: Home respiratory management--an attempt at respiratory physical therapy for neuromuscular diseases Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(Suppl 2): 246-247
1994: Glucocorticoid therapy in obstructive respiratory tract diseases. German Respiratory League Pneumologie 48 Suppl. 1: 334-337
Roldaan, A.C.; Masurel, N.; Zuidema, P. 1978: The significance of respiratory virus infections in chronic aspecific respiratory diseases (CARD) Nederlands Tijdschrift Voor Geneeskunde 122(26): 923-926
Botvin'ev, V.V.; Baranova, N.F.; Sterligov, L.A. 1978: T- and B-immunity systems in acute respiratory and allergic diseases of the respiratory organs in children Vestnik Akademii Meditsinskikh Nauk SSSR 7: 24-29
1994: Recommendations for vocational guidance of adolescents with respiratory tract diseases. German Respiratory League Pneumologie 48 Suppl. 1: 345-348
Akutsu, I.; Motojima, S.; Sagara, H.; Ogata, H.; Otsuka, T.; Fukuda, T.; Ikemori, R.; Makino, S. 1989: Effects of sulbactam/cefoperazone in patients with respiratory infections in aged and/or with underlying respiratory diseases Japanese Journal of Antibiotics 42(4): 910-920
Sereda, E.V.; Lozovskaia, L.S. 1971: Role of respiratory viral infections in the development of exacerbations in protracted and chronic respiratory diseases in children Voprosy Okhrany Materinstva i Detstva 16(10): 14-18
Owsiński, J.; Dolezal, M.; Dolezal, M. 1972: Fungi of the upper respiratory tract and the incidence of chronic respiratory diseases in workers of gypsum industry. I Przeglad Lekarski 29(4): 467-471
Hirota, M.; Hara, K. 1987: Refractory respiratory tract infections. 2. Disorders of the defense mechanism and infection. a. Basic respiratory diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 45(3): 461-466
Chodosowska, E.; Hawryłkiewicz, I.; Pepke, J.; Biernacki, W.; Zieliński, J. 1983: Pulmonary artery pressure and respiratory function in patients with chronic respiratory tract diseases 6 years after the first test Pneumonologia Polska 51(2): 93-99
Dorow, P. 1978: The effect of an oral aminophylline compound with protracted activity on respiratory resistance and blood gases in obstructive respiratory diseases Arzneimittel-Forschung 28(5): 853-856
Giovannini, M.; Rossi, G.A.; Merolla, R.; Arena, F.; Cutrera, R.; Dalla Casa, P.; D'Andrea, N.; Galluzzo, C.; Indinnimeo, L.; Ivaldi, M.; Pifferi, M.; Rinaldi, G.; Torcoletti, M.; Zuccotti, G.V. 2003: Respiratory diseases in infants hospitalized during the 1st 2 years of life for viral lower respiratory tract infections: a one-year follow-up Minerva pediatrica 55(2): 149-155
Kobayashi, N.; Akiya, M. 1980: Bedside conference in pediatric nursing. 10. The nursing of children with respiratory diseases (No. 3), neurologic diseases (No. 2), malignant neoplasms (No. 3), hematologic diseases (No. 5) and kidney Kango Tenbo. Japanese Journal of Nursing Science 5(10): 922-933
Kuno, K.; Ohi, M.; Mishima, M.; Chin, K.; Oku, Y. 1989: Evaluation of respiratory disability in patients of respiratory diseases using relationships between ventilatory drive, ventilation and thoracic pump function during exercise Nihon Kyobu Shikkan Gakkai Zasshi 27(2): 131-136
Paisley, L.G.; Vraa-Andersen, L.; Dybkjaer, L.; Møller, K.; Christensen, G.; Mousing, J.; Agger, J.F. 1993: An epidemiologic and economic study of respiratory diseases in two conventional Danish swine herds. I: Prevalence of respiratory lesions at slaughter and their effects on growth Acta Veterinaria Scandinavica 34(4): 319-329
Medici, M.Cristina.; Arcangeletti, M.Cristina.; Merolla, R.; Chezzi, C. 2004: Incidence of respiratory syncytial virus infection in infants and young children referred to the emergency departments for lower respiratory tract diseases in Italy Acta Bio-Medica: Atenei Parmensis 75(1): 26-33
Herzovi, F. 1978: Recurrent respiratory diseases in young children and the value of nonspecific immunostimulation in the prevention and treatment of such diseases Revista de Pediatrie Obstetrica Si Ginecologie. Pediatria 27(3): 245-248